Denovicon seamlessly integrates AI, machine learning, and molecular modeling approaches (such as quantum chemistry, molecular dynamics, and free-energy methods) into its (hybrid) computational drug discovery platform. With it, a vast amount of chemical space (~10^27 molecules) is quickly and accurately triaged, with only the most desirable analogs being identified as hits that are then ultimately transformed into clinical candidates. 

Biotechnology

Denovicon Therapeutics

Denovicon Therapeutics' headquarters in San Diego, CA, United States

Scott Bembenek

Michael Gilson

Ben E. Black

Denovicon Therapeutics' Leadership Team includes Scott Bembenek.

About

People (1)

Scott Bembenek

Jobs